Login
logo dark logo light logo
  • About EUnetHTA
    • EUnetHTA
      • JA 3 (2016-2020)
      • JA 2 Archive (2012-2015)
      • JA 1 Archive (2010-2012)
      • EUnetHTA Collaboration (2009)
      • EUnetHTA Project (2006-2008)
    • EUnetHTA Network
    • Organisation
      • The Executive Board
      • The Secretariat
    • Vision, Mission, and Values
    • EUnetHTA and the HTA Network
    • EUnetHTA Magazine
      • Winter 2020
      • Autumn 2019
      • Summer 2019
      • Winter 2018-2019
      • Autumn 2018
      • Summer 2018
      • Spring 2018
      • Winter 2017 – 2018
      • Autumn 2017
    • Acronyms
  • Covid-19 Response
    • Diagnostics
    • Treatments
    • Useful Links
  • Services
    • Assessment Submission
    • Early Dialogues
      • Early Dialogues for Pharmaceutical Products
      • Early Dialogues for Medical Devices
    • PLEG
  • Assessments
    • EUnetHTA Prioritisation List (EPL) – Pharmaceuticals
    • EUnetHTA Prioritisation List (EPL) – Other Technologies
    • Assessments REA (2016 – 2021)
    • Topic Identification, Selection and Prioritisation
    • National Uptake and Case Studies
    • PICO FAQ
    • Assessment Archive (2006 – 2015)
    • Assessment FAQ
  • Tools
    • HTA Core Model®
    • Methodology
    • REQueST® Tool
    • POP Database
    • EVIDENT Database
    • Declaration of Interest (DOI)
    • Submission Template for Pharma and Med. Devices
    • Companion Guide
    • Tools Archive
      • HTA Adaptation Toolkit
  • Get Involved
    • Patients
    • Industry
    • Health Care Professionals
    • Payers
    • Events
      • 2021 EUnetHTA Forum
      • 2020 EUnetHTA Forum
      • 2019 EUnetHTA Forum
      • 2018 EUnetHTA Forum
      • 2017 EUnetHTA Forum
      • Upcoming Events
Mobile Logo
  • About EUnetHTA
    • EUnetHTA
      • JA 3 (2016-2020)
      • JA 2 Archive (2012-2015)
      • JA 1 Archive (2010-2012)
      • EUnetHTA Collaboration (2009)
      • EUnetHTA Project (2006-2008)
    • EUnetHTA Network
    • Organisation
      • The Executive Board
      • The Secretariat
    • Vision, Mission, and Values
    • EUnetHTA and the HTA Network
    • EUnetHTA Magazine
      • Winter 2020
      • Autumn 2019
      • Summer 2019
      • Winter 2018-2019
      • Autumn 2018
      • Summer 2018
      • Spring 2018
      • Winter 2017 – 2018
      • Autumn 2017
    • Acronyms
  • Covid-19 Response
    • Diagnostics
    • Treatments
    • Useful Links
  • Services
    • Assessment Submission
    • Early Dialogues
      • Early Dialogues for Pharmaceutical Products
      • Early Dialogues for Medical Devices
    • PLEG
  • Assessments
    • EUnetHTA Prioritisation List (EPL) – Pharmaceuticals
    • EUnetHTA Prioritisation List (EPL) – Other Technologies
    • Assessments REA (2016 – 2021)
    • Topic Identification, Selection and Prioritisation
    • National Uptake and Case Studies
    • PICO FAQ
    • Assessment Archive (2006 – 2015)
    • Assessment FAQ
  • Tools
    • HTA Core Model®
    • Methodology
    • REQueST® Tool
    • POP Database
    • EVIDENT Database
    • Declaration of Interest (DOI)
    • Submission Template for Pharma and Med. Devices
    • Companion Guide
    • Tools Archive
      • HTA Adaptation Toolkit
  • Get Involved
    • Patients
    • Industry
    • Health Care Professionals
    • Payers
    • Events
      • 2021 EUnetHTA Forum
      • 2020 EUnetHTA Forum
      • 2019 EUnetHTA Forum
      • 2018 EUnetHTA Forum
      • 2017 EUnetHTA Forum
      • Upcoming Events

Osteba

Home  /  Osteba

Basque Office for Health Technology Assessment- Ministry for Health
Donostia-San Sebastián 1
Vitoria-Gasteiz
Spain
Tel.: +34945019250
Fax: +34945019280
EMail: osteba-san@euskadi.es
http://www.osakidetza.euskadi.eus/

EUnetHTA involvement

As Associated Partner

  • EUnetHTA Project (2006-08)
    • Project WP4 – Common Core HTA
    • Project WP5 – Adapting HTA
    • Project WP7 – New Technologies
  • EUnetHTA Joint Action 3 (2016-20)
    • Work Package 7 – National implementation and impact
    • Work Package 4 – Joint Production
    • Work Package 5 – Life cycle approach to improve Evidence Generation

As Collaborating partner

  • EUnetHTA Joint Action 2 (2012-15)
    • JA2 WP2 – Dissemination
    • JA2 WP4 – Testing collaborative production of HTA information for national adaptation and reporting
    • JA2 WP5 – Applying the HTA Core Model for Rapid Assessment for national adaptation and reporting
    • JA2 WP7 – Methodology development and evidence generation: Guidelines and pilots production
  • EUnetHTA Joint Action (2010-12)
    • JA WP2 – Dissemination
    • JA WP6 – Information Management System
    • JA WP7 – New Technologies

OUR NETWORK

  • EUnetHTA Network
  • JA 3 (2016-2020)
  • JA 2 Archive (2012-2015)
  • JA 1 Archive (2010-2012)
  • EUnetHTA Collaboration (2009)
  • EUnetHTA Project (2006-2008)

CAREERS

  • Work with EUnetHTA

HELP

Email: eunethta@zinl.nl

CONTACT US

  • Media and Press
  • Disclaimer
  • Reusing our content
  • Terms of use
  • Privacy Policy

This website is part of joint action ‘724130 / EUnetHTA JA3’ which has received funding from the European Union’s Health Programme (2014-2020).

©2018 EUnetHTA All rights reserved.